Stocks and Investing
Stocks and Investing
Wed, June 8, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, June 7, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Douglas Tsao Downgraded (TXMD) to Hold and Held Target at $10 on, Jun 7th, 2022
Douglas Tsao of HC Wainwright & Co., Downgraded "TherapeuticsMD, Inc." (TXMD) to Hold and Held Target at $10 on, Jun 7th, 2022.
Douglas has made no other calls on TXMD in the last 4 months.
There is 1 other peer that has a rating on TXMD. Out of the 1 peers that are also analyzing TXMD, all agrees with Douglas's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Louise Chen of "Cantor Fitzgerald" Downgraded from Buy to Hold and Decreased Target to $50 on, Friday, May 6th, 2022
Contributing Sources